Previous Page  33 / 38 Next Page
Information
Show Menu
Previous Page 33 / 38 Next Page
Page Background

J u n e 1 1 - 1 3 , 2 0 1 8 | D u b l i n , I r e l a n d

allied

academies

Page 57

Note:

CANCER STEM CELLS AND

ONCOLOGY RESEARCH

11

th

International Conference on

Journal of Medical Oncology and Therapeutics

|

Volume 3

Corinne Auge Gouillou et al., J Med Oncl Ther 2018, Volume 3

SETMAR IN GLIOBLASTOMA: SPLICE

VARIANTS AND FEEDBACK NETWORK

IN CONTROLLING TARGET GENES

EXPRESSION

Corinne Auge Gouillou

1

, Sylvaine Renault

1

, Jérôme Jaillet

1

,

Murielle Genty

1

, Edouard Coudert

1

, Oriane Lié

1

and

Ilyess

Zemmoura

2

1

University of Tours, France

2

CHRU of Tours, France

S

ETMAR is a chimeric protein, acting as a house-kipping genome

guardian in healthy cells. In a recent work [i], we demonstrate that

SETMAR expression increases in GBM where different splice variants are

produced depending on the stage of the cells: stem cells express a small

hyper-stable SETMAR (sm-SETMAR) whereas differentiated cells express

a large formknownas the “regular”SETMARenzyme (r-SETMAR).Theonly

difference between both SETMAR proteins originates from the lack of the

SET domain on the sm-SETMAR, due to exon-exclusion during pre-mRNA

maturation. As a result sm-SETMAR is devoid of any methyl-transferase

activity, preventing chromatin modifications and regulations usually

assign to r-SETMAR. In contrast, both proteins are still able to promote

DNA repair by NHEJ, albeit sm-SETMAR is less effective. Our current

works hypothesis that sm-SETMAR may contribute to confer cancer stem

cells properties of chimio- and radio-resistance, in addition to alter their

normal epigenetic profile. Because SETMAR originates from a mobile

genetic element, the human genome contains of thousands of SETMAR

DNA binding sites that are in fact fossils of the original transposon. They

together constitute a regulatory network. The characterization of target

genes differentially regulated by the one or other one of the SETMAR

proteins through this network during GBM biogenesis is under progress.

Corinne Auge Gouillou has completed her PhD

at the Pasteur Institute of Paris in 1993 and

postdoctoral studies from Tours University. She

has been leading her research team for over 15

years and published more than 25 papers in re-

puted journals. She is very strongly involved in

teaching and pedagogy, especially for young

students who arrive at the University. She has

been serving as a referee for many journals, and

led a French network dedicated to mobile DNA.

auge@univ-tours.fr

BIOGRAPHY